ARS Pharmaceuticals Chief Commercial Officer Margaret Ekins Smith files initial beneficial ownership statement
Reuters2026/08/17 20:45- ARS Pharmaceuticals Chief Commercial Officer Margaret Ekins Smith filed an initial Form 3 on Aug. 17, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Dollar: Range-bound support as Fed priced – ING
GBP/JPY Price Forecast: Six-month lows at the 209.20 area under pressure
Temple Bar Investment Trust Sept. 4 estimated NAV with debt at par value at 413.32 pence/share
The yield on the 10-year US Treasury is approaching the 5.5% red line! Societe Generale warns: Stock valuation support is failing, US stocks may face a severe shock.
Société Générale pointed out that this year’s global profit expectations have been significantly raised. Even with rising yields, this has prevented equity risk premiums from plunging.
Crypto prices
More
